ASTERASYS Co.,Ltd
Research ASTERASYS Co.,Ltd (450950.KQ) on Bullrun: market cap KRW 198.30B, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker450950.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 198.30B
- Dividend yield1.0%
- Financial periodQ2 2026
- RevenueKRW 11.22B
- Net incomeKRW 1.30B
- Free cash flowKRW 1.57B
- Gross margin79.7%
Valuation Snapshot
latest market cap is KRW 198.30B; dividend yield is 1.0%.
Peer valuation comparison
Latest dividend yield is 0.99% versus a Healthcare sector median of 2.4% (58.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 198.30B | n/a | 1.0% | 52 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 52 KRW, yield 1.0%.
About ASTERASYS Co.,Ltd
ASTERASYS Co.,Ltd manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand. The company offers Coolfase, a monopolar RF device with direct cooling in tip; Q-facial, a skin management equipment; Liftera for facial skin lifting; Liftera2, a dual-type HIFU technology that enables combination treatments using Line and Pen-type applicators;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ASTERASYS Co.,Ltd's market cap?
ASTERASYS Co.,Ltd's market capitalization is KRW 198.30B.
Does ASTERASYS Co.,Ltd pay a dividend?
ASTERASYS Co.,Ltd has a dividend yield of 1.0%.
What does ASTERASYS Co.,Ltd do?
ASTERASYS Co.,Ltd manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand. The company offers Coolfase, a monopolar RF device with direct cooling in tip; Q-facial, a skin management equipment; Liftera for facial skin lifting; Liftera2, a dual-type HIFU technology that enables combination treatments using Line and Pen-type applicators; and Futera Dots for fractional skin resurfacing.